Introductory text
United Kingdom
Commission Decision
of 8 February 1993
laying down the criteria for vaccines to be used against Newcastle disease in the context of routine vaccination programmes
(93/152/EEC)
THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Economic Community,
Whereas Annex III of Directive 90/539/EEC states that the Commission may determine the criteria for using vaccines against Newcastle disease in the context of routine vaccination programmes;
Whereas the said criteria shall ensure that live attenuated and inactivated vaccines used in routine vaccination programmes fulfil certain requirements relating in the intracerebral pathogenicity index (ICPI) in respect of the Newcastle disease virus strain used in the said vaccines;
Whereas it seems desirable that the level of intracerebral pathogenicity index virus strains to be used in vaccine production should be clearly defined;
Whereas the Scientific Veterinary Committee and the Standing Veterinary Committee have been consulted,
HAS ADOPTED THIS DECISION: